Stephen G. Maher

2.3k citations

52 papers · 1.8k indexed · h-index 20

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Immunology top 5%
- Immune Cell Function and Interaction
- interferon and immune responses

Papers in

Cancer Research 17
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 4
Oncology 25
- Cancer Immunotherapy and Biomarkers 12
- Pancreatic and Hepatic Oncology Research 8

Co-authors: John V. Reynolds Niamh Lynam‐Lennon Catriona Miller Howard A. Young Ana L. Romero-Weaver Anthony J. Scarzello Ana M. Gamero Claire Condron
Journals: Scientific Reports (3 papers)Translational Oncology (3 papers)Radiation Research (2 papers)Cancer Letters (2 papers)Radiotherapy and Oncology (2 papers)
Partner nations: Ireland United Kingdom Canada

In The Last Decade

Stephen G. Maher

51 papers receiving 1.8k citations

Peers

Countries citing papers authored by Stephen G. Maher

Since Specialization

Citations

This map shows the geographic impact of Stephen G. Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen G. Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen G. Maher more than expected).

Fields of papers citing papers by Stephen G. Maher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen G. Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen G. Maher. The network helps show where Stephen G. Maher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen G. Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen G. Maher Line = papers co-authored together Stephen G. Maher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development Scientific Reports ·ヒロミチニシムラ, Helena Telles Antunes, CD Nwani, O'hea Aj, Simone Marcone, Caitríona Scaife, Elaine Kenny, Michael Henry, Paula Meleady, Paul F. Ridgway, 公孝永島, Kevin C. Conlon, Barbara M. Ryan, Stephen G. Maher	2025	2
2	Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia Cancer Letters ·李盛彪, Andrea Scuderi, 魏光清, D T Burwell, Ian S. Miller, Lasse Jensen, Adriele Prina‐Mello, Niamh Lynam‐Lennon, Stephen G. Maher, Helena Kelly, Jacintha O’Sullivan	2024	1
3	Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis Cancer Research Communications ·ヒロミチニシムラ, Edgar Camilo Vargas Aldana, CD Nwani, Rebecca O’Brien, Fiona O’Connell, Odi Andanu, Ida Ayu Gede Bintang Praba Dewi, Khanh T. Nguyen, David Mockler, Aidan D. Meade, Barbara M. Ryan, Stephen G. Maher	2022	29
4	PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours Translational Oncology ·Maria Davern, Shane Bookhultz, Odi Andanu, S.A. Hebisha, Noel E. Donlon, Beatrice Nosco, Yoichiro Matsubara, Zhimin Zhang, Conall Hayes, Jamie Macdonald, Mario Fernando Pomaquero Caín, John V. Reynolds, Stephen G. Maher, Niamh Lynam‐Lennon, Brona M. Murphy, Joanne Lysaght	2022	6
5	FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy Journal of Cancer Research and Clinical Oncology ·Maria Davern, Noel E. Donlon, Jhenny Patricia, Νάντερ Μπατίχη, Yoichiro Matsubara, S.A. Hebisha, Jean-Claude Bolay, Ángela Liliana Martínez Rodríguez, Conall Hayes, Dara Bracken‐Clarke, Melissa J. Conroy, B Cagáňová, Dermot O’Toole, Kenneth Yamoah, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, 陈红媛, Joanne Lysaght	2022	1
6	Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma World Journal of Gastroenterology ·Noel E. Donlon, Maria Davern, Fiona O’Connell, Jhenny Patricia, S.A. Hebisha, Kenneth Yamoah, Christine Butler, Narayanasamy Ravi, Claire Donohoe, J.J. Phelan, Niamh Lynam‐Lennon, Margaret R. Dunne, Stephen G. Maher, Jacintha O’Sullivan, John V. Reynolds, Joanne Lysaght	2022	8
7	PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma British Journal of Radiology ·Samuel Cure, Isaline Renard, R. L. Elliott, Chun Li, Nadine M. Jernewall, Rajarshi Roy, Andrew Beavis, Stephen J. Archibald, Christopher Cawthorne, Stephen G. Maher, Isabel M. Pires	2021	2
8	Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells Translational Oncology ·Maria Davern, Noel E. Donlon, Jhenny Patricia, Yoichiro Matsubara, Conall Hayes, Kenneth Yamoah, B Cagáňová, Dermot O’Toole, Niamh Lynam‐Lennon, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Joanne Lysaght	2021	12
9	Selective effects of radiotherapy on viability and function of invariant natural killer T cells in vitro Radiotherapy and Oncology ·Ashanty M. Melo, Stephen G. Maher, Seónadh M. O’Leary, Derek G. Doherty, Joanne Lysaght	2020	3
10	Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8+ T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients Frontiers in Immunology ·Melissa J. Conroy, Stephen G. Maher, Ashanty M. Melo, Suzanne L. Doyle, B Cagáňová, John V. Reynolds, Aideen Long, Joanne Lysaght	2018	31
11	Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma Clinical & Translational Oncology ·Ann Mongan, Niamh Lynam‐Lennon, Nicholas Davidson, Stephen G. Maher, Graham P. Pidgeon, John V. Reynolds, Jeff O’Sullivan	2015	5
12	MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma PLoS ONE ·B. Bibby, John V. Reynolds, Stephen G. Maher	2015	33
13	Radiation Sensitivity of Esophageal Adenocarcinoma: The Contribution of the RNA-Binding Protein RNPC1 and p21-Mediated Cell Cycle Arrest to Radioresistance Radiation Research ·شريف سعاد, Niamh Lynam‐Lennon, John V. Reynolds, Stephen G. Maher	2012	26
14	Barretts to Oesophageal Cancer Sequence: A Model of Inflammatory-Driven Upper Gastrointestinal Cancer Digestive Surgery ·Sarah Picardo, Stephen G. Maher, Jacintha O’Sullivan, John V. Reynolds	2012	52
15	Alterations in DNA Repair Efficiency are Involved in the Radioresistance of Esophageal Adenocarcinoma Radiation Research ·Niamh Lynam‐Lennon, John V. Reynolds, Graham P. Pidgeon, Joanne Lysaght, Laure Marignol, Stephen G. Maher	2010	65
16	Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer International Journal of Colorectal Disease ·Dermot T. McDowell, F. M. Smith, John V. Reynolds, Stephen G. Maher, J Namiesnik, Paul Crotty, Eoin F. Gaffney, Donal Hollywood, Brian Mehigan, R. B. Stephens, Michael J. Kennedy	2009	10
17	Clinical Use of Interferon‐γ Annals of the New York Academy of Sciences ·Catriona Miller, Stephen G. Maher, Howard A. Young	2009	241
18	Gene Expression Analysis of Diagnostic Biopsies Predicts Pathological Response to Neoadjuvant Chemoradiotherapy of Esophageal Cancer Annals of Surgery ·Stephen G. Maher, Charles Gillham, Shane P. Duggan, Estela Uy Clemente, Nicola Miller, Cian Muldoon, Kenneth J. O’Byrne, Orla Sheils, Donal Hollywood, John V. Reynolds	2009	4
19	Differential gene expression profiles as markers of radioresistance in esophageal cancer Cancer Research ·Stephen G. Maher, Niamh Lynam‐Lennon, John V. Reynolds	2008	1
20	IFN-α and IFN-λ differ in their antiproliferative effects and duration of JAK/STAT signaling activity Cancer Biology & Therapy ·Stephen G. Maher, Faruk Sheikh, Anthony J. Scarzello, Ana L. Romero-Weaver, Darren P. Baker, Raymond P. Donnelly, Ana M. Gamero	2008	133

About Stephen G. Maher

Stephen G. Maher is a scholar working on Cancer Research, Oncology, Immunology, Surgery and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 1.8k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (22 papers), Cancer Immunotherapy and Biomarkers (12 papers), MicroRNA in disease regulation (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Lung Cancer Treatments and Mutations (5 papers), Immune cells in cancer (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (646 citations), Immunology (528 citations), Oncology (514 citations), Molecular Biology (853 citations) and Internal Medicine (31 citations). Stephen G. Maher has collaborated with scholars based in Ireland, United Kingdom and Canada. Frequent co-authors include John V. Reynolds, Niamh Lynam‐Lennon, Catriona Miller, Howard A. Young, Ana L. Romero-Weaver, Anthony J. Scarzello, Ana M. Gamero, Claire Condron, Deirdre Toomey and Graham P. Pidgeon. Their work appears in journals such as Scientific Reports, Translational Oncology, Radiation Research, Cancer Letters and Radiotherapy and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact